Printer Friendly

Browse Mycoses topic

Drug therapy subtopic

 

Articles

1-95 out of 95 article(s)
Title Author Type Date Words
Remetinostat Phase II Data Demonstrate Efficacy on Skin Lesions, Reduction of Itching and High Tolerability in Patients With Early-stage MF-type CTCL. Oct 13, 2017 1378
US Food and Drug Administration Grants Breakthrough Therapy Designation for Mogamulizumab for the Treatment of Mycosis Fungoides and Sezary Syndrome. Aug 25, 2017 564
Global Health Solutions Partners with Camargo Pharmaceutical Services for Onychomycosis Development Program. Aug 21, 2017 746
Amplyx Pharmaceuticals' APX001 receives USFDA orphan drug designation. Nov 18, 2016 125
Amplyx Pharmaceuticals' APX001 receives USFDA orphan drug designation. Nov 18, 2016 121
FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Multiple Invasive Fungal and Mold Infections. Nov 16, 2016 642
Moberg Pharma announces start of patient enrolment in North America and Europe in two Phase 3 studies of MOB-015 in onychomycosis. Sep 29, 2016 217
Moberg Pharma announces start of patient enrolment in North America and Europe in two Phase 3 studies of MOB-015 in onychomycosis. Sep 29, 2016 213
Tinea and onychomycosis. Rosen, Theodore Sep 1, 2016 2947
Pulmatrix Receives Orphan Drug Designation from the FDA for Inhaled Drug to Treat Pulmonary Fungal Infections in Cystic Fibrosis Patients. Aug 17, 2016 1200
Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective. Okumura, Lucas Miyake Letter to the editor Jul 1, 2016 441
Antifungal drugs for onychomycosis: efficacy, safety, and mechanisms of action. Rosen, Theodore; Gold, Linda F. Stein Apr 1, 2016 3286
Study: Pulmatrix's PUR1900 Inhaled Cystic Fibrosis Drug Demonstrates High Lung Retention and Potency Against Fungal Infection. Oct 8, 2015 991
Rare severe mycotic infections in children receiving empirical caspofungin treatment for febrile neutropenia. Karapinar, Deniz Yilmaz; Karadas, Nihal; Sivis, Zuhal Onder; Yazici, Pinar; Duyu, Muhterem; Metin, D Report Sep 1, 2015 2441
Efficacy and safety of onychomycosis treatments: an evidence-based overview. Pariser, David M.; Jellinek, Nathaniel J.; Rich, Phoebe Aug 1, 2015 5893
Understanding onychomycosis treatment: mechanisms of action and formulation. Jellinek, Nathaniel J.; Rich, Phoebe; Pariser, David M. Drug overview Aug 1, 2015 2468
Clinical evaluation of efficacy of sertaconazole 2% cream in treatment of pityriasis versicolor and a comparision with that of clotrimazole 1% cream. Tatavarthi, N.B. Lakshmi; Ramachandra, B.V.; Rao, D. Subba; Srinivasulu, G. Report Apr 2, 2015 2131
Astellas receives approval for Cresemba from US FDA. Mar 10, 2015 170
Astellas receives approval for Cresemba from US FDA. Mar 10, 2015 166
Chromoblastomycosis in a resident of a leprosarium. Dashatwar, Digambar; Kar, Sumit; Gangane, Nitin; Pol, Vijay; Madke, Bhushan; Kulkarni, Sandeep; Sing Report Mar 1, 2015 1201
SCYNEXIS wins US FDA's fast track designation for oral formulation of novel antifungal product SCY-078. Jan 12, 2015 185
SCYNEXIS wins US FDA's fast track designation for oral formulation of novel antifungal product SCY-078. Jan 12, 2015 181
Fixed drug eruption due to fluconazole: a case report. Vora, Rita Vipul; Mehta, Malay J.; Diwan, Nilofar G.; Gor, Alpa P.; Gajjar, Bharat M. Sep 1, 2014 1188
Post-operative management of Allergic fungal sinusitis (ASF): role of Itraconazole. Dhote, Kanchan S.; Dhoke, Priti R.; Harkare, V.V.; Deosthale, N.V.; Khadakkar, Sonali P. Report Aug 4, 2014 2242
Valeant Pharmaceuticals Announces FDA Approval Of Jublia for the Treatment of Onychomycosis. Jun 9, 2014 1263
Valeant Pharmaceuticals wins US FDA approval for Jublia to treat onychomycosis of the toenails. Jun 9, 2014 234
Valeant Pharmaceuticals wins US FDA approval for Jublia to treat onychomycosis of the toenails. Jun 9, 2014 230
Fungal infections of the feet. McIntosh, Iain B. Report Jan 1, 2014 1498
Valeant Pharmaceuticals Announces U.S. Approval Of Luzu Cream, 1%. Nov 15, 2013 846
Detection of synergistic combinations of Baccharis extracts with terbinafine against Trichophyton rubrum with high throughput screening synergy assay (HTSS) followed by 3D graphs. Behavior of some of their components. Rodriguez, Maria Victoria; Sortino, Maximiliano A.; Ivancovich, Juan J.; Pellegrino, Jose M.; Favier Report Oct 15, 2013 6874
Valeant Pharmaceuticals Announces Approval Of Jublia For The Treatment Of Onychomycosis In Canada. Oct 3, 2013 1015
Astellas reports positive topline phase 3 results for antifungal isavuconazole. Clinical report Sep 30, 2013 1085
Current and emerging options in the treatment of onychomycosis. Elewshi, Boni; Pariser, David; Rich, Phoebe; Scher, Richard K. Sep 1, 2013 3423
Current and emerging options in the treatment of onychomycosis. Elewski, Boni; Pariser, David; Rich, Phoebe; Scher, Richard K. Sep 1, 2013 3425
Fungal infections can trigger and exacerbate asthma. Sep 1, 2013 967
Effectiveness of chloroxylenol and chlorhexidine--cetrimide disinfectants on fungal isolates from clinically suspected cases of uncomplicated otomycosis. Sharada, Mannur; Neelesh, Naik; Swaroop, Jyothi; Waseem, Shah; Hiremath, Savitha; Nagaraj, E.R. Report Aug 26, 2013 1372
Anacor Pharmaceuticals submits first NDA to the FDA for tavaborole for topical treatment of onychomycosis. Jul 30, 2013 172
Anacor Pharmaceuticals submits first NDA to the FDA for tavaborole for topical treatment of onychomycosis. Jul 30, 2013 158
FDA Approves Pediatric Indication for Astellas' MYCAMINE (micafungin sodium) for Injection. Jun 24, 2013 1261
Basileaa[euro](tm)s isavuconazole granted orphan drug designation by US FDA. May 28, 2013 246
Basileaa[euro](tm)s isavuconazole granted orphan drug designation by US FDA. May 28, 2013 242
Q/Which oral antifungal works best for toenail onychomycosis? Volk, Brad; Tiu, Alvin; Anna, Leilani St. Feb 1, 2013 1025
Ceptaris Announces Publication in JAMA Dermatology of Positive Clinical Results for Mechlorethamine Gel in Early Stage Mycosis Fungoides, the Most Common Type of Cutaneous T-Cell Lymphoma. Jan 30, 2013 517
Seattle Genetics Receives FDA Orphan Drug Designation for ADCETRIS[R] (Brentuximab Vedotin) in Mycosis Fungoides. Nov 26, 2012 1736
PinPointe[TM] FootLaser[TM] Surpasses 100,000 Treatments for Onychomycosis. Nov 5, 2012 510
Mylan Inc unveils generic Sporanox capsules for fungal infections in the lungs. Jul 30, 2012 169
Anacor Pharmaceuticals Completes Enrollment in Second of Two Phase 3 Trials of Tavaborole for Onychomycosis. Dec 22, 2011 528
Valeant Announces Successful Results From Phase III Onychomycosis Trials. Dec 16, 2011 645
Anacor Pharmaceuticals Completes Enrollment in First of Two Phase 3 Trials of AN2690 for Onychomycosis. Nov 9, 2011 665
FDA Accepts Filing of New Drug Application (NDA) for Yaupon's Proprietary Gel Formulation of Mechlorethamine Hydrochloride. Oct 4, 2011 528
Fatal fungal infections resist newest class of drugs. Brief article Oct 1, 2011 302
Onychomycosis: oral/topical combo superior. Jancin, Bruce Clinical report Aug 1, 2011 177
Yaupon Therapeutics, Inc. Submits New Drug Application for Proprietary Gel Formulation of Mechlorethamine Hydrochloride. Jul 28, 2011 560
Drug Humira Causes Veteran's Near Death and Debilitating Fungal Infection. Jun 13, 2011 546
Candida species isolated from the vaginal mucosa of HIV-infected women in Salvador, Bahia, Brazil. Oliveira, Paula Matos; Mascarenhas, Rita Elizabeth; Lacroix, Claire; Ferrer, Suzana Ramos; Oliveira, May 1, 2011 3288
Early treatment strategy boosts onychomycosis cure rate. Jancin, Bruce Feb 1, 2011 726
NB Therapeutics completes enrollment in Phase II onychomycosis study. Jan 6, 2011 214
Expert suggests changes in fungus treatment. Harrison, Laird Report Jan 1, 2011 546
Anacor Pharmaceuticals Announces First Patient Dosed in a Phase 3 Trial of AN2690 For Onychomycosis. Dec 16, 2010 660
Tx strategies boost onychomycosis cure rate. Jancin, Bruce Report Dec 1, 2010 603
PURE Bioscience's SDC Antimicrobial Effective Against T. mentagrophytes in Preclinical Tests. Aug 2, 2010 989
Rhinoentomophthoromycosis: rarity revisited. Bhatia, Naresh; Singh, Charu; Kawatra, Rahul; Alam, Seraj; Dhawan, Ruchir Case study Jun 1, 2010 1034
Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis. Clinical report Apr 30, 2010 1064
Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis. Clinical report Apr 30, 2010 1088
Early detection of pulmonary fungal infection by CT scan in pediatric ALL patients under chemotherapy or in post-transplantation period with primary complaint of chest pain/Gogus agrisi ile basvuran pediatrik akut lenfoblastik losemi olgularinda kemoterapi sirasinda ya da kok hucre nakli sonrasi gelisen pulmoner fungal enfeksiyonun bilgisayarli tomografi ile erken tayini. Unal, Sule; Kuskonmaz, Baris; Tavil, Betul; Elmas, Selin Aytac; Cetinkaya, Duygu Uckan; Cetin, Muall Report Mar 1, 2010 2696
Invasive fungal diseases in children with hematologic disorders/Hematolojik hastalikli cocuklarda invazif fungal infeksiyonu. Baytan, Birol; Gunes, Adalet Meral; Celebi, Solmaz; Gunay, Unsal Clinical report Dec 1, 2009 5429
Research and Markets: Onychomycosis Therapy Area Pipeline Report - Detailed Information on the Onychomycosis Drug Pipeline. Report Aug 12, 2009 344
Breast cancer drug effective against life-threatening fungal infections too. Jul 21, 2009 423
Forward modeling of the Coumarin Antifungals; SPR/SAR based perspective. Soltani, Saeed; Dianat, Shima; Sardari, Soroush Report Jul 1, 2009 3064
Synthesis of 1-(4-hydroxylphenyl)-4-(4-nitrophenyl) piperazine. Chang-mei, Ke; Ning, Tang; Yong, Hu; Quan-quan, Wang Report Jun 30, 2009 1224
Infections in children due to Candida and non-Candidal yeasts/Cocuklarda Candida ve Candida disi maya enfeksiyonlari. Soysal, Ahmet Report May 1, 2009 1535
Treatment of invasive fungal infections/Invazif mantar enfeksiyonlarinin tedavisi. Somer, Ayper Report May 1, 2009 2117
Anti-fungal medication may benefit patients with severe asthma. Dec 29, 2008 338
Certain drugs linked to higher death risk: researchers suggest asking your physician for alternative therapies. Dec 1, 2008 649
Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags. Adams, Andrea I.H.; Morimoto, Lucia N.; Meneghini, Leonardo Z.; Bergold, Ana M. Oct 1, 2008 3975
New Research Reveals That Mycamine(R) is an Effective Treatment in Children, Young Babies and Premature Infants. Aug 28, 2008 980
Posaconazole (Noxafil): a new triazole antifungal agent. Greer, Nickie D. Drug overview Apr 1, 2007 7111
New antifungals just in time to counter a surge; a garden variety of T. rubrum is showing resistance. Autoimmunity and mobility probably play a role. Goldman, Erik L. Jan 15, 2007 1085
New drugs could slow rise in fungal infections. Goldman, Erik L. Nov 1, 2006 1077
New azole found to prevent invasive fungal infections. Walsh, Nancy Disease/Disorder overview May 15, 2006 397
Aerosol amphotericin B in the works as fungal prophylaxis. Walsh, Nancy May 1, 2006 404
Aerosolized amphotericin B in the works as a fungal prophylaxis. Apr 15, 2006 396
A human fungicide ... for plants? Wedge, David F. Brief Article Sep 1, 2005 142
New antifungals boast fewer drug interactions: the echinocandins' lower potential for interactions makes them "ideal" for combination therapies. McNamara, Damian May 1, 2005 740
What is angular cheilitis and how is it treated? Skinner, Nadine; Junker, Jessie A.; Flake, Donna May 1, 2005 1027
Low-dose fluconazole may prevent invasive fungal infection in newborns. Brunk, Doug Jan 1, 2005 482
Probiotic no help against yeast infection. Evans, Jeff Brief Article Jan 1, 2005 200
Reinforcements arriving in the fungal arena: more echinocandins coming. Wachter, Kerri Jul 1, 2004 997
New antifungals offer improved efficacy, safety. Wachter, Kerri Jun 15, 2004 761
Eye trauma often behind fungal infections. Wachter, Kerri Jun 1, 2004 364
Voriconazole: salvage therapy. Worcester, Sharon Brief Article Aug 1, 2003 174
Voriconazole: the newest triazole antifungal agent. Greer, Nickie D. Drug overview Apr 1, 2003 7270
Antifungal Arsenal to expand in 2002. (More Immunocompromised Patients). Jancin, Bruce Brief Article Jan 1, 2002 412
Expanding antifungal armamentarium welcomed. (Second-generation Drugs). Jancin, Bruce Brief Article Jan 1, 2002 600
Aggressive combination treatment for invasive fungal sinusitis in immunocompromised patients. Mudan, Satvinder Apr 1, 2000 2862

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters